Nanoscale Drug Delivery Systems for Glaucoma: Experimental and In Silico Advances

• Published in: Current topics in medicinal chemistry Vol. 21; no. 2; p. 115
• Main Authors: Sharma, Smriti, Bhatia, Vinayak
• Format: Journal Article
• Language: English
• Published: United Arab Emirates 01.01.2021
• Subjects: Ocular drugs; Computational drug delivery; In silico; Drug delivery; Posterior eye segment; Ocular drug delivery; Anti-glaucoma drugs
• ISSN: 1873-4294
• DOI: 10.2174/1568026620666200922114210

In this review, nanoscale-based drug delivery systems, particularly in relevance to the antiglaucoma drugs, have been discussed. In addition to that, the latest computational/in silico advances in this field are examined in brief. Using nanoscale materials for drug delivery is an ideal option to target tumours, and the drug can be released in areas of the body where traditional drugs may fail to act. Nanoparticles, polymeric nanomaterials, single-wall carbon nanotubes (SWCNTs), quantum dots (QDs), liposomes and graphene are the most important nanomaterials used for drug delivery. Ocular drug delivery is one of the most common and difficult tasks faced by pharmaceutical scientists because of many challenges like circumventing the blood-retinal barrier, corneal epithelium and the blood-aqueous barrier. Authors found compelling empirical evidence of scientists relying on in-silico approaches to develop novel drugs and drug delivery systems for treating glaucoma. This review in nanoscale drug delivery systems will help us understand the existing queries and evidence gaps and will pave the way for the effective design of novel ocular drug delivery systems.